Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
about
Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapyOncolytic virus therapy: A new era of cancer treatment at dawnRetargeting Strategies for Oncolytic Herpes Simplex VirusesProgresses towards safe and efficient gene therapy vectorsOncolytic virotherapy using herpes simplex virus: how far have we come?Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyOncolytic virus therapy for glioblastoma multiforme: concepts and candidatesOncolytic viral therapy for pancreatic cancer: current research and future directionsVirotherapy: cancer gene therapy at last?Downregulation of KIF23 suppresses glioma proliferationCellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.Effect of ultrasound on herpes simplex virus infection in cell culture.Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas.Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice.Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma.A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.Presage of oncolytic virotherapy for oral cancer with herpes simplex virus.B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cellsHypoxia enhances the replication of oncolytic herpes simplex virusVirotherapy against malignant glioma stem cellsPhase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBMA herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer.Herpes simplex virus oncolytic therapy for pediatric malignanciesEvaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates.Mechanism and application of genetic recombination in herpesviruses.Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells.Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitorsAttenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in miceAttenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.Genetically engineered HSV in the treatment of glioma: a review.Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus.A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animalsConditionally replicating herpes vectors for cancer therapy.Chemotherapy for high-grade gliomas.Biological approaches to therapy of pancreatic cancer.Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer.Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesOncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?
P2860
Q24679781-5F5866AD-DEC7-4165-9695-2F6CAE973E0DQ26739714-655ACDC2-88DA-40B6-9631-5C59C39EA646Q26765439-DFD8D3DC-5212-4D98-81CC-D0ADA569AD3CQ26781432-E97D30E2-2049-432F-8CCA-245C2C1F32E7Q26862461-9318FE5C-EFC2-4BAB-B77A-9D95D2DFC391Q26998111-4A361764-F04E-4290-A342-9C4AF69B9A19Q27007519-B7BD37E9-61FE-453B-8A8A-2B00BDD0D76FQ27011439-1A81F013-6AA6-45A7-8DBC-432C9BACDF3EQ28066228-B7472112-AB80-45BF-BB24-3E52450DEC67Q28247603-0EEB6A17-999B-44EA-9BF7-4D8A3DFF7C0BQ30395978-83C749E4-9C06-4BA6-A72C-736BE9FB3175Q30473768-FC65357B-6223-4E81-A108-494E21EEE7B4Q30775012-C9F8BE4C-2E2C-438D-8148-928D90AE1242Q30826113-FCD82E6B-1769-482D-9918-A25C40DC23FBQ33484184-F4F2860E-1CE6-43DE-863D-4EC014601BA3Q33523284-BF849E11-854C-4D40-9FB6-044268E2E826Q33579396-5C8BF2A2-774D-4C49-8FA4-E78B45EE1467Q33587028-1A114FEA-8229-40C2-9994-917CD861B188Q33603748-C2CAFB3E-1C4C-47F4-85C5-F7A71368B47CQ33649894-B0765F05-5A25-49BE-AECF-0476A1C7964AQ33660631-CCA8FF52-48BD-4670-964D-09A7ADE0B1D3Q33665530-B0313D5B-3FB4-425A-8337-C884F4AB41E1Q33712977-DF72EA8E-E368-4A79-8B38-DD61AC496901Q33713249-25EE6570-968D-456A-9853-67C68656CE2BQ33713824-1D6AC7F4-58D3-42C0-AC0A-3C970A3F714BQ33720628-D433EE1F-7753-4B1C-8334-900C6F10D12AQ33729830-E7852DE3-6790-441F-8A24-9873B36EB60BQ33755158-D5631642-94BF-4C79-8FD2-2F92E8FEED9AQ33794302-B8F30BF8-D1C0-40D8-851E-4FB515B36E8AQ33802747-5A0783AE-9521-4504-A58A-288972566396Q33816579-E79E0BFF-F52F-4FD9-A520-D1EE9E3E18C0Q33827571-70912872-1186-406B-BD8D-61217EC758DDQ33844465-285A1F2F-0346-4D71-AFC4-7B20132917BAQ33851852-C6413F67-207F-4CC1-A935-83C80403213EQ33882697-5CD9FBA4-F830-42FC-A751-0A72DC0C9226Q33898570-9F4E77AB-1CE4-4E98-AE54-0FA661CCBEC7Q33899938-9D833AC6-686A-4853-9FE2-07A18FC62DD1Q33904270-B3BFC71F-D159-4DF1-859D-3DCC1DDC6F64Q33924550-BC861C31-CC81-4E9F-9005-F62B5BF018B2Q33995471-1AD72B0E-7A2A-4D1D-9E0C-C958DC0E6C60
P2860
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
@ast
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
@en
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
@nl
type
label
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
@ast
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
@en
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
@nl
prefLabel
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
@ast
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
@en
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
@nl
P2093
P356
P1433
P1476
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
@en
P2093
P2888
P304
P356
10.1038/NM0995-938
P407
P577
1995-09-01T00:00:00Z
P6179
1047705565